CD4 Counts at Entry to HIV Care in Mexico for Patients under the “Universal Antiretroviral Treatment Program for the Uninsured Population,” 2007–2014

• Alfonso C. Hernández-Romieu,

  Affiliations Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States of America, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States of America

  ⨯
• Carlos del Rio,

  Affiliations Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States of America, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States of America, Center for AIDS Research, Emory University, Atlanta, GA, United States of America

  ⨯
• Juan Eugenio Hernández-Ávila,

  Affiliation National Institute of Public Health (INSP), Cuernavaca, Mexico

  ⨯
• Hugo Lopez-Gatell,

  Affiliation National Institute of Public Health (INSP), Cuernavaca, Mexico

  ⨯
• José Antonio Izazola-Licea,

  Affiliations National Center for Prevention and Control of HIV/AIDS (CENSIDA), Mexico City, Mexico, Joint United Nations Programme on HIV/AIDS (UNAIDS), Evaluation and Economics Division, Geneva, Switzerland

  ⨯
• Patricia Uribe Zúñiga,

  Affiliation Joint United Nations Programme on HIV/AIDS (UNAIDS), Evaluation and Economics Division, Geneva, Switzerland

  ⨯
• Mauricio Hernández-Ávila

  * E-mail: mhernan@insp.mx

  Affiliation National Institute of Public Health (INSP), Cuernavaca, Mexico

  ⨯